1. Home
  2. LSTA vs SPCB Comparison

LSTA vs SPCB Comparison

Compare LSTA & SPCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LSTA
  • SPCB
  • Stock Information
  • Founded
  • LSTA 1980
  • SPCB 1988
  • Country
  • LSTA United States
  • SPCB Israel
  • Employees
  • LSTA N/A
  • SPCB N/A
  • Industry
  • LSTA Misc Health and Biotechnology Services
  • SPCB Semiconductors
  • Sector
  • LSTA Health Care
  • SPCB Technology
  • Exchange
  • LSTA Nasdaq
  • SPCB Nasdaq
  • Market Cap
  • LSTA 31.2M
  • SPCB 31.4M
  • IPO Year
  • LSTA N/A
  • SPCB N/A
  • Fundamental
  • Price
  • LSTA $2.64
  • SPCB $9.37
  • Analyst Decision
  • LSTA Strong Buy
  • SPCB Strong Buy
  • Analyst Count
  • LSTA 1
  • SPCB 1
  • Target Price
  • LSTA $15.00
  • SPCB $18.00
  • AVG Volume (30 Days)
  • LSTA 72.4K
  • SPCB 780.5K
  • Earning Date
  • LSTA 02-27-2025
  • SPCB 11-14-2024
  • Dividend Yield
  • LSTA N/A
  • SPCB N/A
  • EPS Growth
  • LSTA N/A
  • SPCB N/A
  • EPS
  • LSTA N/A
  • SPCB 1.02
  • Revenue
  • LSTA N/A
  • SPCB $26,843,000.00
  • Revenue This Year
  • LSTA N/A
  • SPCB $6.72
  • Revenue Next Year
  • LSTA N/A
  • SPCB $16.91
  • P/E Ratio
  • LSTA N/A
  • SPCB $9.50
  • Revenue Growth
  • LSTA N/A
  • SPCB 5.23
  • 52 Week Low
  • LSTA $2.19
  • SPCB $2.55
  • 52 Week High
  • LSTA $4.20
  • SPCB $18.95
  • Technical
  • Relative Strength Index (RSI)
  • LSTA 42.17
  • SPCB 46.90
  • Support Level
  • LSTA $2.45
  • SPCB $9.21
  • Resistance Level
  • LSTA $2.74
  • SPCB $11.43
  • Average True Range (ATR)
  • LSTA 0.32
  • SPCB 1.74
  • MACD
  • LSTA -0.05
  • SPCB -0.67
  • Stochastic Oscillator
  • LSTA 16.48
  • SPCB 1.64

About LSTA Lisata Therapeutics Inc.

Lisata Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative therapies for the treatment of advanced solid tumors and other major diseases. Its product candidate, LSTA1, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively.

About SPCB SuperCom Ltd. (Israel)

SuperCom Ltd is an Israel-based provider of traditional and digital identity solutions, providing safety, identification, tracking, and security products to governments and organizations. The company comprises three main Strategic Business Units: e-Gov; IoT and Connectivity, which is the key revenue driver; and Cyber Security. Besides, it also offers a wide range of solutions that include national ID registries, e-passports, biometric visas, automated fingerprint identification systems, digitized driver's licenses, and electronic voter registration and election management using the common platform. The geographical segments of the company include Africa, European countries, South America, the United States, Israel, and the Asia Pacific.

Share on Social Networks: